58 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding plans, expectations and anticipated milestones
8-K
EX-99.1
ppk znna20x
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
EX-99.1
d7dy4gv5
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.2
dl1hw7ux1wkzkr1w 3h
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
wxzbbqskto8kl8 sjg
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.2
qp57sb
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
uddniu
7 Dec 23
Other Events
7:45am
8-K
EX-99.1
ba211x5q
7 Dec 23
Other Events
7:45am
8-K
EX-99.1
qp2 icrbp
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
8-K
li99pxdz37x6esw1v8j
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
4929r 824g1ha2
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
fswqzjdmxmmo
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
f8q8vw59qvbv6uii
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am